157 related articles for article (PubMed ID: 23001726)
1. The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells.
Saito Y; Suzuki H; Imaeda H; Matsuzaki J; Hirata K; Tsugawa H; Hibino S; Kanai Y; Saito H; Hibi T
Int J Cancer; 2013 Apr; 132(8):1751-60. PubMed ID: 23001726
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between the expression level of miR-29c and biological behavior of gastric cancer].
Ma XQ; Wang LP; Luo QC; Cai JC
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):325-30. PubMed ID: 24054006
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines.
Sitarz R; Leguit RJ; de Leng WW; Morsink FH; Polkowski WP; Maciejewski R; Offerhaus GJ; Milne AN
Cell Oncol; 2009; 31(6):475-85. PubMed ID: 19940363
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.
Lu K; Feng F; Yang Y; Liu K; Duan J; Liu H; Yang J; Wu M; Liu C; Chang Y
J Gastroenterol; 2020 Jan; 55(1):51-66. PubMed ID: 31562534
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
He XP; Shao Y; Li XL; Xu W; Chen GS; Sun HH; Xu HC; Xu X; Tang D; Zheng XF; Xue YP; Huang GC; Sun WH
FEBS J; 2012 Nov; 279(22):4201-12. PubMed ID: 23013439
[TBL] [Abstract][Full Text] [Related]
6. microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
Yu B; Chen X; Li J; Gu Q; Zhu Z; Li C; Su L; Liu B
BMC Cancer; 2017 Feb; 17(1):109. PubMed ID: 28173777
[TBL] [Abstract][Full Text] [Related]
7. APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes.
Magalhães L; Quintana LG; Lopes DCF; Vidal AF; Pereira AL; D'Araujo Pinto LC; de Jesus Viana Pinheiro J; Khayat AS; Goulart LR; Burbano R; de Assumpção PP; Ribeiro-Dos-Santos Â
BMC Cancer; 2018 Oct; 18(1):1055. PubMed ID: 30376837
[TBL] [Abstract][Full Text] [Related]
8. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS
J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.
Liu L; Bi N; Wu L; Ding X; Men Y; Zhou W; Li L; Zhang W; Shi S; Song Y; Wang L
Mol Cancer; 2017 Feb; 16(1):50. PubMed ID: 28241836
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
Saito T; Tamura D; Asano R
Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823].
Li Q; Peng J; Zhang GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1123-8. PubMed ID: 19141979
[TBL] [Abstract][Full Text] [Related]
12. MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.
Matsuo M; Nakada C; Tsukamoto Y; Noguchi T; Uchida T; Hijiya N; Matsuura K; Moriyama M
Mol Cancer; 2013 Feb; 12():15. PubMed ID: 23442884
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells.
Liu H; Huang P; Xu X; Liu J; Guo C
Dig Dis Sci; 2009 Jul; 54(7):1418-24. PubMed ID: 18923901
[TBL] [Abstract][Full Text] [Related]
14. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
[TBL] [Abstract][Full Text] [Related]
15. MiR-29c suppresses cell invasion and migration by directly targeting CDK6 in gastric carcinoma.
Jiang H; Liu ZN; Cheng XH; Zhang YF; Dai X; Bao GM; Zhou LB
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7920-7928. PubMed ID: 31599417
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of S100P by lentiviral-mediated RNAi promotes apoptosis and suppresses the colony-formation ability of gastric cancer cells.
Zhang Q; Hu H; Shi X; Tang W
Oncol Rep; 2014 May; 31(5):2344-50. PubMed ID: 24677114
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells.
Deng Y; Su Q; Mo J; Fu X; Zhang Y; Lin EH
Cancer Invest; 2013 Feb; 31(2):97-102. PubMed ID: 23245395
[TBL] [Abstract][Full Text] [Related]
19. [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
Ran JT; Zhou YN; Tang CW; Lu JR; Wu J; Lu H; Yang GD
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):448-51. PubMed ID: 19024521
[TBL] [Abstract][Full Text] [Related]
20. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]